Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review

被引：0
|
作者：
Zohreh Maghsoomi
Zahra Emami
Ramin Malboosbaf
Mojtaba Malek
Mohammad E. Khamseh
机构：
[1] Iran University of Medical Science (IUMS),Endocrine Research Center, Institute of Endocrinology and Metabolism
[2] Iran University of Medical Sciences (IUMS),Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism
来源：
BMC Cancer | / 21卷
关键词：
Peptide receptor radionuclide therapy; Radioiodine refractory-differentiated thyroid Cancer; Medullary thyroid carcinoma; Papillary thyroid carcinoma; Yttrium-90; 177Lu-DOTATATE; Indium-111; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Grande, Enrique
    Kreissl, Michael C.
    Filetti, Sebastiano
    Newbold, Kate
    Reinisch, Walter
    Robert, Caroline
    Schlumberger, Martin
    Tolstrup, Laerke K.
    Zamorano, Jose L.
    Capdevila, Jaume
    ADVANCES IN THERAPY, 2013, 30 (11) : 945 - 966
  • [32] Safety and Efficacy of Peptide Receptor Radionuclide Therapy after Liver Transplantation in Metastatic Neuroendocrine Tumors
    Kulkarni, H.
    Kaemmerer, D.
    Hoersch, D.
    Hommann, M.
    Baum, R. P.
    NEUROENDOCRINOLOGY, 2012, 96 : 42 - 43
  • [33] Meta-Analysis of the Efficacy and Safety Evaluation of Vandetanib in the Treatment of Medullary Thyroid Cancer
    Xian, Tong-cheng
    Yang, Min-ye
    Zhang, Xue-lin
    Wang, Jie
    Luo, Yi
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (09) : 649 - 653
  • [34] Incidence, Recurrence and Mortality Among Filipinos With Differentiated Thyroid Cancer: A Systematic Review
    Juan, Mari Des San
    Paz-Pacheco, Elizabeth
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, : 100 - 107
  • [35] Prognostic role and characteristics of the indeterminate response in differentiated thyroid cancer: a systematic review
    Bellini, P.
    Dondi, F.
    Gatta, E.
    Zilioli, V.
    Albano, D.
    Cappelli, C.
    Bertagna, F.
    ENDOCRINE, 2024, 84 (03) : 812 - 821
  • [36] A retrospective review of the multidisciplinary management of medullary thyroid cancer: Eligibility for systemic therapy
    Geller G.
    Laskin J.
    Cheung W.Y.
    Ho C.
    Thyroid Research, 10 (1)
  • [37] 'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'
    Satapathy, Swayamjeet
    Mittal, Bhagwant Rai
    Bhansali, Anil
    CLINICAL ENDOCRINOLOGY, 2019, 91 (06) : 718 - 727
  • [38] Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
    Amerein, Adriana
    Maurer, Christoph
    Kircher, Malte
    Gable, Alexander
    Krebold, Anne
    Rinscheid, Andreas
    Viering, Oliver
    Pfob, Christian H.
    Bundschuh, Ralph A.
    Behrens, Lars
    Braat, Arthur J. A. T.
    Berlis, Ansgar
    Lapa, Constantin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1911 - 1916
  • [39] Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis
    Huy Gia Vuong
    An Thi Nhat Ho
    Tran, Thao T. K.
    Capdevila, Jaume
    Benekli, Mustafa
    Nakazawa, Tadao
    Katoh, Ryohei
    Kondo, Tetsuo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (08): : 2823 - 2829
  • [40] Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors
    Alayli, Adam
    Ngo, Hoang
    Sikaria, Dhiraj
    Ahmed, Altan
    Salloum, Elias
    Strosberg, Jonathan R.
    Al-Toubah, Taymeyah E.
    Kis, Bela
    Haider, Mintallah
    El-Haddad, Ghassan
    CANCERS, 2024, 16 (15)
12345